Skip to content
Advertisement

This September 2020 photo provided by Johnson & Johnson shows the investigational Janssen COVID-19 vaccine. Johnson & Johnson's long-awaited COVID-19 vaccine appears to protect against symptomatic illness with just one shot — not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses. (Cheryl Gerber/Johnson & Johnson via AP)

This September 2020 photo provided by Johnson & Johnson shows the investigational Janssen COVID-19 vaccine. Johnson & Johnson's long-awaited COVID-19 vaccine appears to protect against symptomatic illness with just one shot — not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses. (Cheryl Gerber/Johnson & Johnson via AP)

Featured Photo Galleries